AKT1 and inflammatory bowel disease: Our previous study (13) also indicated that GPR109A mediated the function of sodium butyrate in inhibiting inflammation and protecting the intestinal epithelial barrier in the TNBS-induced IBD mouse model by inhibiting the phosphorylation of AKT and NF-Kb p65 signaling pathways.